NOXXON PHARMA NV:
* NOXXON PHARMA ANNOUNCES PROSPECTUS PUBLICATION AND SHARE TRANSFER TO THE PUBLIC OFFERING COMPARTMENT OF THE EURONEXT GROWTH MARKET
* NOXXON PHARMA ANNOUNCES PROSPECTUS PUBLICATION AND SHARE TRANSFER TO THE PUBLIC OFFERING COMPARTMENT OF THE EURONEXT GROWTH MARKET
* ISSUANCE OF FIRST TRANCHE OF ODIRNANE BONDS FOR EUR 1 MILLION
* CO CAN REQUIRE ISSUANCE OF FURTHER FIVE TRANCHES OF EUR 500,000 WHETHER OR NOT ALL CONVERTIBLE NOTES OF PREVIOUS TRANCHE HAVE BEEN FULLY CONVERTED OR REDEEMED
* CONVERSION OF AN ADDITIONAL EUR 841,000(1) OF KREOS DEBT INTO SHARES AT A PRICE PER SHARE EQUAL TO LOWER OF EUR 15.50
* KREOS WILL ALSO RECEIVE 45,219 SHARE WARRANTS WITH AN EXERCISE PRICE OF EUR 18.60
* THESE SHARE WARRANTS WILL HAVE SAME CHARACTERISTICS AS BSA SHARE WARRANTS ATTACHED TO ODIRNANE BONDS Source text for Eikon: Further company coverage: (Gdynia Newsroom)